Cargando…

Editorial: Tumor microenvironment targeted nanomedicine: a feasible strategy for cancer imaging and theranostics

Detalles Bibliográficos
Autores principales:	Xu, Yiming, Jiang, Dawei, Chen, Weiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283035/ https://www.ncbi.nlm.nih.gov/pubmed/37350950 http://dx.doi.org/10.3389/fonc.2023.1228910

Ejemplares similares

Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021)

Editorial: Advanced Theranostic Nanomedicine in Oncology
por: Tapeinos, Christos, et al.
Publicado: (2020)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
por: Chen, Shanshan, et al.
Publicado: (2023)

Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine
por: Yun, Tian, et al.
Publicado: (2022)

UCNP-based Photoluminescent Nanomedicines for Targeted Imaging and Theranostics of Cancer
por: Guryev, Evgenii L., et al.
Publicado: (2020)

Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases
por: Patel, Sravan Kumar, et al.
Publicado: (2015)

Editorial: Advances in the Understanding of Tumor Microenvironment: Molecular and Theranostic Imaging
por: Wang, Shouju, et al.
Publicado: (2021)

Nanomedicines Targeting Metabolism in the Tumor Microenvironment
por: Ren, Mengdi, et al.
Publicado: (2022)

Editorial: Unveiling the Impact of Local or Systemic Therapeutic Strategies on the Tumor Microenvironment
por: Chen, Yun-Wang, et al.
Publicado: (2022)

Editorial: Novel Targets and Targeting Technologies to Modulate Tumor Microenvironment
por: Prakash, Jai, et al.
Publicado: (2016)

In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine
por: Chen, Feng, et al.
Publicado: (2015)

Editorial: Tumor microenvironment in bladder cancer
por: Kusmartsev, Sergei, et al.
Publicado: (2023)

Editorial: Proteoglycans in the Tumor Microenvironment
por: Brunetti, Jlenia, et al.
Publicado: (2022)

Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2019)

Theranostic nanomedicine for cancer detection and treatment
por: Fan, Zhen, et al.
Publicado: (2014)

Editorial: Radiomics-based theranostics in cancer precision medicine
por: Ji, Jiansong, et al.
Publicado: (2023)

Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
por: Pu, Zhangya, et al.
Publicado: (2022)

Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy
por: Lee, So Yun, et al.
Publicado: (2020)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

Advanced Peptide Nanomedicines for Bladder Cancer Theranostics
por: Zeng, Sheng, et al.
Publicado: (2022)

Nanotheranostics ˗ Application and Further Development of Nanomedicine Strategies for Advanced Theranostics
por: Muthu, Madaswamy S., et al.
Publicado: (2014)

Editorial: Impact of tumor microenvironment on lung cancer
por: Levantini, Elena
Publicado: (2023)

Editorial: Tumor microenvironment in primary brain cancers
por: Niechi, Ignacio, et al.
Publicado: (2023)

Nanozymes in Tumor Theranostics
por: Ma, Qiulian, et al.
Publicado: (2021)

Editorial: The interconnection between epigenetic modifications and the tumor microenvironment
por: He, Siyuan, et al.
Publicado: (2023)

Mechanical Properties in the Glioma Microenvironment: Emerging Insights and Theranostic Opportunities
por: Bhargav, Adip G., et al.
Publicado: (2022)

Editorial: Megakaryocytes as regulators of tumor microenvironments
por: Migliaccio, Anna Rita, et al.
Publicado: (2022)

Theranostic Probes for Targeting Tumor Microenvironment: An Overview
por: Sikkandhar, Musafar Gani, et al.
Publicado: (2017)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Theranostic nanomedicine: Potential therapeutic epitome
por: Nagaich, Upendra
Publicado: (2015)

Corrigendum: Theranostic Nanomedicine for Malignant Gliomas
por: d'Angelo, Michele, et al.
Publicado: (2020)

Industrialization’s eye view on theranostic nanomedicine
por: Sivasubramanian, Maharajan, et al.
Publicado: (2022)

Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023)

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
por: Xu, Yanyan, et al.
Publicado: (2022)

Advances in nanotheranostics II: cancer theranostic nanomedicine
por: Dai, Zhifei
Publicado: (2016)

Stimuli-activatable nanomedicine meets cancer theranostics
por: Li, Haonan, et al.
Publicado: (2023)

Editorial: Tumor Microenvironment and Resistance to Current Therapies
por: Lasfar, Ahmed, et al.
Publicado: (2019)

Editorial: The effects of chemotherapy towards the tumor microenvironment
por: Abu, Nadiah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2b9niqhqa0g3b8dqf867d7opm